Executive Director HEOR and R&D International

Urovant Sciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for urological conditions. 

Every employee at Urovant plays an integral role to our success.  We are ambitious in our approach to improving outcomes for the patients and healthcare providers we serve.  Our fast-paced environment rewards strategic decision-making and collaboration, giving team members opportunities to grow beyond their expertise.

The Company's current area of research focus is Urological disease.  Urovant Sciences is currently investigating treatments for OAB in men with benign prostatic hyperplasia (BPH), as well as an earlier stage gene-therapy for OAB in patients who have failed oral pharmacologic therapy.  Urovant Sciences, a subsidiary of Sumitovant Biopharma Ltd., intends to develop novel treatments for additional urologic diseases. Learn more at www.urovant.com.

Position Description

The Executive Director / VP Health Economics & Outcomes Research (HEOR) and Research and Development (R&D) International will develop the strategy and provide the internal expertise, guidance and oversight to the design, methodologies, analytic techniques and reporting of heath economic research and outcomes (HEOR). This will include pharmacoeconomic models for all markets, as indicated, selection of appropriate vendors, facilitating discussions with HEOR KOLs and other clinical/academic consultants, identification of pharmacoeconomic data gaps.

The Executive Director / VP HEOR and R&D International will lead Urovant Sciences in HEOR strategies and tactics for economic value and quality of life questionnaires and arguments and recommend the appropriate instruments during clinical development and product launch to support pricing and reimbursement across global payor and health systems, in close collaboration with the SVP, Medical Affairs.  The role will cover US, prioritized International Developed Markets (IDM) and international markets as needed.

In addition, this role will work closely with the EVP and Chief Medical Office Urovant Sciences, to provide input into the R&D strategy for key assets; review and approve standard operating procedures (SOPs) and supervise and manage R&D staff based in Switzerland. The incumbent will also participate in the monthly progress reviews of all global projects and will help represent Urovant interests to other groups within the broader holding company.

Key Duties and Responsibilities

• Develop and execute strategy for global HEOR strategic and tactical efforts that align with Market Access, Clinical Development, and Marketing strategy to optimize access & reimbursement for Urovant products.
• Lead and execute local market specific (i.e., Europe) Health Technology Assessment (HTA) submissions, including value framework reports in collaboration with cross-functional colleagues and appropriate vendors.
• Leadership and execution of HEOR studies and projects in collaboration with global and local strategy to support differentiated value proposition for Urovant products and collaborate with business partners as needed.
• Development of healthcare resource utilization (HCRU) endpoints and identification of appropriate patient reported outcomes (PROs) for clinical trials and observational studies across all phases of product development.
• Explore new concepts that are complex to advance innovative processes and methodologies based on comprehensive business knowledge, e.g., preferred formulary positioning, and value-based contracts.
• Support additional indications, life cycle management and overall Urology portfolio strategy in value evidence generation and reimbursement.
• Lead the strategy for, development of, submissions to, and interactions with payor groups, regulatory authorities, the HEOR scientific community, and relevant vendors while maintaining knowledge of industry and policy trends that may impact patient access and reimbursement for Urovant Science products.
• Maintain and develop strong relationships and visibility with external KOLs in medicine, health economics, and outcomes research.
• Develop and recommend quality of life or other patient-reported outcomes for clinical trials.
• Deliver clinical presentations and communications focused on evidence based HEOR, economic models, and dossiers, and any other tools that support global reimbursement and access requirements.
• Function as a liaison between various team members and technical resources to drive the creation of systems and processes that help harmonize and optimize the planning, execution, tracking and delivery of HTA dossier content and local data generation non-interventional studies.
• Manage the global HEOR/RWE budget and the vendors for evidence generation, analytics, and related activities.
• Provide input into the R&D strategy.
• Contribute to business development and due diligence initiatives.
• Recommend process improvement.
• Review and approve SOPs.
• Supervise and manage R&D personnel based in Switzerland.
• Actively participate in the R&D leadership meeting and monthly progress reviews of global projects.
• Represent Urovant interests to other groups within the broader holding company.
• Be willing and able to work across time zones.

Education and Experience

• PhD, PharmD or MD in a scientific field and experience conducting HEOR research on an international scale.
• Minimum of 10-years of demonstrated ability to conduct pharmacoeconomic, health policy, health program evaluation in the international biopharmaceutical industry (large and/or small companies) or a minimum of 5 years academically and then a minimum of 5 years in the international biopharmaceutical industry.
• Experience with global markets.
• Experience in clinical studies with HEOR endpoints and recommendation of appropriate questionnaires.
• Experience in analysis of US claims databases and/or electronic health records (EHRs)/electronic medical records (EMRs).
• Experience in managing HEOR vendors internationally and managing HEOR budgets.
• Experience in economic model development to assess the value of medical products.
• Energized being in a fast-paced entrepreneurial environment.
• Experience managing and supervising personnel.

Essential Skills and Abilities

• Leadership capabilities for cross functional teams.
• Good organizational skills.
• Good communication skills, both verbally and in writing.
• Good presentation skills, including presentations to Executive management and external audiences and experts.
• Ability to work across locations and time zones.
• Ability to work on several projects and assignments at the same time.
• Ability to prioritize tasks and work across time zones.
• A commitment to collaborative leadership, management, teamwork, delegation, and the maintenance of a professional culture based on trust and mutual respect.

To ensure the health and safety of our workforce while doing our part to protect those around us, Urovant Sciences is requiring proof of full COVID vaccination for US and Global employees as a condition of employment to the extent permissible under federal and state laws and subject to legally-recognized accommodations.

#LI-hybrid